Navigation Links
Pew and the Stewart Trust launch scholars program targeting cancer
Date:6/23/2014

PhiladelphiaThe Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology.

"Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital for the development of novel therapies," said Rebecca W. Rimel, Pew's president and CEO. "We are delighted to partner with the Stewart Trust to expand our commitment to science and eagerly anticipate the discoveries these talented researchers will make to address these challenges."

Pew has supported innovative research by young scientists through its biomedical scholars program http://www.pewtrusts.org/projects/pew-biomedical-scholars/ since 1985 and through the Pew Latin American fellows program http://www.pewtrusts.org/projects/pew-latin-american-fellows/ launched in 1991.

"Some of the most important health advances have stemmed from curiosity-driven investigations, and young researchers seem particularly primed to seed innovation in the field of cancer," said William Bierbower, executive trustee for the Stewart Trust, which for over 15 years has backed researchers probing the mechanisms of cancer.

"By combining forces with Pew, whose biomedical programs set the standard for selecting outstanding researchers, we believe we can leverage the most talented scientific minds to discover novel means of preventing, treating, and eventually curing cancer."

The Pew-Stewart scholars are assistant professor-level cancer researchers. They receive funding over four years and will have the opportunity to collaborate with Pew biomedical scholars and Latin American fellows at Pew's annual biomedical meeting.

Also announced today were the newest members of Pew's biomedical scholars and Latin American fellows programs, which support groundbreaking research by promising early-career biomedical researchers in the United States and Latin America.

The 2014 Pew-Stewart Scholars for Cancer Research are:

Arvin Dar, Ph.D.
Icahn School of Medicine at Mount Sinai
Oncology and chemical biology

Andrew Holland, Ph.D.
Johns Hopkins University School of Medicine
Cell biology and oncology

Shawn Douglas, Ph.D.
University of California, San Francisco
Pharmacology and nanotechnology

Agnel Sfeir, Ph.D.
New York University School of Medicine
Chromosome biology

Roberto Zoncu, Ph.D.
University of California, Berkeley
Cell biology and cancer metabolism

For the scholars' full abstracts and for more information about the program, please visit http://www.pewtrusts.org/projects/Pew-Stewart-Scholars-for-Cancer-Research/.


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Related biology news :

1. Entrust to Address Attendees, Exhibit at ICAO Eighth Symposium and Exhibition on MRTDs, Biometrics and Security Standards
2. Study details essential role of trust in agricultural biotech partnerships
3. $1 million Kenan Trust Grant extends support of Scripps Florida education outreach
4. Salk Institute awarded historic $42 million grant from the Helmsley Charitable Trust
5. Dont trust liposomes in your beauty products
6. CellTrust SecureSMS PULSE Integrated to Santech Health for Secure Text Messaging of Biometrics and PHI will be Demonstrated at HIMSS 2013
7. Many stressors associated with fracking due to perceived lack of trust, Pitt finds
8. Roy J. Carver Charitable Trust funds new research focus at Institute for Genomic Biology
9. Trust in leaders, sense of belonging stir people to safeguard common goods, analysis shows
10. Southerners are less trusting, but trust is a factor in environmental cooperation, study shows
11. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: